LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research

Clinical trial NCT02231164 · TERMINATED

Trial details

NCT number: NCT02231164
Sponsor: Boehringer Ingelheim
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2014-10-14
Primary completion: 2015-12-24
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.